Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 EUR | -1.61% | -1.61% | -18.39% |
Apr. 26 | Mib up; US stocks up after PCE data | AN |
Apr. 25 | Bioera on top; Softlab in the red. | AN |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Capitalization 1 | - | 37.4 | 30.27 |
Enterprise Value (EV) 1 | - | 38.42 | 32.02 |
P/E ratio | 59.9 x | - | 9.56 x |
Yield | - | - | - |
Capitalization / Revenue | - | 1.89 x | 1.26 x |
EV / Revenue | - | 1.94 x | 1.33 x |
EV / EBITDA | - | 9.6 x | 7.86 x |
EV / FCF | - | 17,493,811 x | -24,789,197 x |
FCF Yield | - | 0% | -0% |
Price to Book | 7.81 x | - | 3.21 x |
Nbr of stocks (in thousands) | - | 13,454 | 13,454 |
Reference price 2 | 3.360 | 2.780 | 2.250 |
Announcement Date | 5/6/21 | 4/6/23 | 4/6/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net sales 1 | 13.63 | 14.33 | 19.77 | 24.02 |
EBITDA 1 | 3.844 | 3.443 | 4 | 4.072 |
EBIT 1 | 3.578 | 3.14 | 3.818 | 3.879 |
Operating Margin | 26.25% | 21.91% | 19.31% | 16.15% |
Earnings before Tax (EBT) 1 | 3.544 | -0.642 | 4.099 | 4.118 |
Net income 1 | 2.571 | 0.476 | 3.066 | 3.168 |
Net margin | 18.86% | 3.32% | 15.51% | 13.19% |
EPS | - | 0.0561 | - | 0.2355 |
Free Cash Flow | - | 8.497 | 2.196 | -1.292 |
FCF margin | - | 59.29% | 11.11% | -5.38% |
FCF Conversion (EBITDA) | - | 246.79% | 54.9% | - |
FCF Conversion (Net income) | - | 1,785.06% | 71.62% | - |
Dividend per Share | - | - | - | - |
Announcement Date | 5/6/21 | 5/6/21 | 4/6/23 | 4/6/23 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net Debt 1 | 0.41 | - | 1.01 | 1.75 |
Net Cash position 1 | - | 1.04 | - | - |
Leverage (Debt/EBITDA) | 0.1056 x | - | 0.2532 x | 0.4303 x |
Free Cash Flow | - | 8.5 | 2.2 | -1.29 |
ROE (net income / shareholders' equity) | - | -24.7% | 41.6% | 41% |
ROA (Net income/ Total Assets) | - | 14.7% | 9.97% | 9.42% |
Assets 1 | - | 3.236 | 30.76 | 33.63 |
Book Value Per Share | - | 0.4300 | - | 0.7000 |
Cash Flow per Share | - | 0.1100 | - | 0.1600 |
Capex | - | 0.01 | 0.15 | 0.21 |
Capex / Sales | - | 0.08% | 0.74% | 0.86% |
Announcement Date | 5/6/21 | 5/6/21 | 4/6/23 | 4/6/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-18.39% | 17.52M | |
-12.23% | 194B | |
+0.74% | 166B | |
+2.19% | 153B | |
+4.34% | 99.85B | |
+7.04% | 77.56B | |
+19.09% | 73.55B | |
-7.30% | 71B | |
-20.54% | 52.81B | |
+0.53% | 47.86B |
- Stock Market
- Equities
- SFT Stock
- Financials Softlab S.p.A.